Pharmaceutical Purchasing Archive

China Restructures its Drug Pricing Regime

In early May 2015, China’s National Development and Reform Commission (“NDRC”), together with six other agencies, issued aCircular Concerning Opinions on Advancing the Drug Pricing Reform (“Opinions”).1 The Opinions initiate a groundbreaking reform of the drug pricing system in China. Until now, pursuant to China’s Drug Administration Law and related policies and regulations, the government

Patents: A Way of growth for Pharmaceutical Companies

Recent developments in the pharma sector, triggering the concerns of  cold wars amongst few companies pertaining to the patents for certain drugs, it only reflects as to how standard are our patenting laws, and what are the pro’s and con’s of the international patenting procedures of various countries, and how it implicates the growth of